Randomized Controlled Trial to Evaluate the Impact of XDEMVY on Demodex Blepharitis in Soft Contact Lens Wearers
Latest Information Update: 19 Nov 2024
At a glance
- Drugs Lotilaner (Primary)
- Indications Blepharitis
- Focus Therapeutic Use
- Acronyms Ariel
- Sponsors Tarsus Pharmaceuticals
Most Recent Events
- 13 Nov 2024 According to Tarsus Pharmaceuticals media release, results of an ongoing Demodex blepharitis study expected in 2025.
- 22 Mar 2024 Planned End Date changed from 1 Aug 2024 to 1 Dec 2024.
- 22 Mar 2024 Planned primary completion date changed from 1 Aug 2024 to 1 Dec 2024.